Search Results 401-410 of 20298 for Off-label

  1. A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression - Mayo Clinic

    A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian ...

  2. Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

    Dose escalation study to determine the maximum tolerated dose of NEOD001 in approximately 30 subjects with AL amyloidosis. Expansion phase to evaluate safety, ...

  3. A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites - Mayo Clinic

    The study is a multi-center, prospective, open label, uncontrolled feasibility study enrolling 30 patients with refractory or recurrent ascites and cirrhosis at ...

  4. Pilocarpine (ophthalmic route) - Side effects & dosage - Mayo Clinic

    For non-prescription products, read the label or package ingredients carefully. Pediatric. Vuity® eye drops and Qlosi™ eye drops are not indicated for use in ...

  5. Lidocaine (intradermal route) - Side effects & uses - Mayo Clinic

    For non-prescription products, read the label or package ingredients carefully. ... If it does get on these areas, rinse it off right away. ... These side effects ...

  6. An Open Label Extension Study of BMS-911543 In Subjects With Myelofibrosis - Mayo Clinic

    The purpose of this study is to provide patients with myleofibrosis (MF) who participated in study CA215001 access to BMS-911543. Participation eligibility.

  7. Oxybutynin (oral route) - Side effects & dosage - Mayo Clinic

    Follow your doctor's orders or the directions on the label. The following ... Store the medicine in a closed container at room temperature, away from heat, ...

  8. A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum - Mayo Clinic

    Clinical Trials · A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma Gangrenosum · More about research at Mayo Clinic · Mayo ...

  9. Pilot Open-Label Trial Of Resistant Potato Starch In Patients With Cirrhosis And Overt Hepatic Encephalopathy - Mayo Clinic

    From this study, we will be able to understand the influence of resistant potato starch on the gut microbiome and SCFA production, thought to be an important ...

  10. Sulindac (oral route) - Side effects & dosage - Mayo Clinic

    Follow your doctor's orders or the directions on the label. The following ... Store the medicine in a closed container at room temperature, away from heat, ...